Resultats de la cerca - Jamie Geier
- Mostrar 1 - 9 resultats de 9
-
1
-
2
-
3
Completed and Attempted Suicides Among 18,154 Subjects With Schizophrenia Included in a Large Simple Trial per W. Wolfgang Fleischhacker, John M. Kane, Jamie Geier, Onur N. Karayal, Sheela Kolluri, Sybil M. Eng, Robert F. Reynolds, Brian L. Strom
Publicat 2014Artigo -
4
Tofacitinib, an oral Janus kinase inhibitor: analysis of malignancies across the rheumatoid arthritis clinical development programme per Jeffrey R. Curtis, Eun Bong Lee, Irina V Kaplan, Kenneth Kwok, Jamie Geier, Birgitta Benda, Koshika Soma, Lisy Wang, Richard J. Riese
Publicat 2015Revisão -
5
Cardiovascular safety findings in patients with rheumatoid arthritis treated with tofacitinib, an oral Janus kinase inhibitor per Christina Charles‐Schoeman, Pierre Wicker, Miguel Á. González‐Gay, M. Boy, Andrea Zuckerman, Koshika Soma, Jamie Geier, Kenneth Kwok, Richard J. Riese
Publicat 2016Artigo -
6
Systematic review and meta-analysis of serious infections with tofacitinib and biologic disease-modifying antirheumatic drug treatment in rheumatoid arthritis clinical trials per Vibeke Strand, Sima Ahadieh, Jonathan French, Jamie Geier, Sriram Krishnaswami, Sujatha Menon, Tina Checchio, Thomas G. Tensfeldt, Elaine Hoffman, Richard J. Riese, M. Boy, Juan J. Gómez‐Reino
Publicat 2015Revisão -
7
Pregnancy Outcomes in the Tofacitinib Safety Databases for Rheumatoid Arthritis and Psoriasis per Megan E. B. Clowse, Steven R. Feldman, John D. Isaacs, Alexa B. Kimball, Vibeke Strand, Richard B. Warren, Daniel Xibillé, Yan Chen, Donald E. Frazier, Jamie Geier, James Proulx, Amy Marren
Publicat 2016Artigo -
8
Long-term safety of tofacitinib for the treatment of rheumatoid arthritis up to 8.5 years: integrated analysis of data from the global clinical trials per Stanley Cohen, Yoshiya Tanaka, Xavier Mariette, Jeffrey R. Curtis, Eun Bong Lee, Peter Nash, Kevin Winthrop, Christina Charles‐Schoeman, Krishan Thirunavukkarasu, Ryan DeMasi, Jamie Geier, Kenneth Kwok, Lisy Wang, Richard J. Riese, J. Wollenhaupt
Publicat 2017Artigo -
9
Postapproval Comparative Safety Study of Tofacitinib and Biological Disease‐Modifying Antirheumatic Drugs: 5‐Year Results from a United States–Based Rheumatoid Arthritis Registry... per Joel M. Kremer, Clifton O. Bingham, Laura C. Cappelli, Jeffrey D. Greenberg, Ann Madsen, Jamie Geier, Jose L. Rivas, Alina M. Onofrei, Christine Barr, Dimitrios A. Pappas, Heather J. Litman, Kimberly J. Dandreo, Andrea Shapiro, Carol A. Connell, Arthur Kavanaugh
Publicat 2021Artigo
Eines de cerca:
Matèries relacionades
Internal medicine
Medicine
Rheumatoid arthritis
Tofacitinib
Dermatology
Janus kinase inhibitor
Adverse effect
Cancer
Oncology
Pharmacology
Randomized controlled trial
Skin cancer
Surgery
Abatacept
Adalimumab
Biology
Cholesterol
Confidence interval
Conventional PCI
Genetics
Hazard ratio
Incidence (geometry)
Injury prevention
Janus kinase
Law
Lipoprotein
Logistic regression
Lymphoma
MEDLINE
Mace